A detailed history of American Portfolios Advisors transactions in Dexcom Inc stock. As of the latest transaction made, American Portfolios Advisors holds 2,307 shares of DXCM stock, worth $185,874. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,307
Holding current value
$185,874
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$76.35 - $94.18 $176,139 - $217,273
2,307 New
2,307 $186 Million
Q2 2022

Mar 20, 2023

BUY
$67.99 - $132.89 $15,773 - $30,830
232 Added 10.06%
2,539 $189 Million
Q1 2022

Mar 21, 2023

SELL
$94.08 - $130.2 $93,703 - $129,679
-996 Reduced 43.17%
1,311 $671 Million
Q4 2021

Mar 21, 2023

SELL
$129.87 - $162.82 $51,168 - $64,151
-394 Reduced 17.08%
1,913 $1.03 Billion
Q3 2021

Mar 22, 2023

SELL
$106.71 - $143.18 $116,634 - $156,495
-1,093 Reduced 47.38%
1,214 $664 Million
Q2 2021

Mar 22, 2023

SELL
$80.99 - $107.93 $105,934 - $141,172
-1,308 Reduced 56.7%
999 $427 Million
Q1 2021

Mar 22, 2023

SELL
$84.79 - $104.74 $159,574 - $197,120
-1,882 Reduced 81.58%
425 $153 Million
Q4 2020

Mar 22, 2023

SELL
$78.0 - $104.5 $150,462 - $201,580
-1,929 Reduced 83.62%
378 $140 Million
Q3 2020

Mar 22, 2023

SELL
$95.51 - $112.95 $81,852 - $96,798
-857 Reduced 37.15%
1,450 $598 Million
Q2 2020

Mar 24, 2023

BUY
$62.68 - $105.34 $314,841 - $529,122
5,023 Added 338.71%
6,506 $2.64 Billion
Q1 2020

Mar 24, 2023

SELL
$47.79 - $75.63 $39,378 - $62,319
-824 Reduced 35.72%
1,483 $399 Million
Q4 2019

Mar 24, 2023

SELL
$36.62 - $57.29 $81,918 - $128,157
-2,237 Reduced 96.97%
70 $15.3 Million
Q2 2019

Mar 24, 2023

SELL
$27.84 - $38.92 $62,278 - $87,064
-2,237 Reduced 96.97%
70 $10.5 Million
Q1 2019

Mar 24, 2023

BUY
$28.07 - $38.18 $982 - $1,336
35 Added 140.0%
60 $7.15 Million
Q4 2018

Mar 24, 2023

SELL
$26.99 - $37.37 $269 - $373
-10 Reduced 28.57%
25 $3 Million
Q3 2018

Mar 24, 2023

SELL
$23.35 - $36.72 $53,051 - $83,427
-2,272 Reduced 98.48%
35 $5.01 Million
Q2 2018

Mar 24, 2023

SELL
$17.54 - $25.22 $1,227 - $1,765
-70 Closed
0 $0
Q1 2018

Mar 24, 2023

SELL
$13.06 - $18.54 $29,215 - $41,473
-2,237 Reduced 96.97%
70 $5.19 Million
Q4 2017

Mar 24, 2023

SELL
$11.12 - $15.38 $25,209 - $34,866
-2,267
40 $2.3 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.